US 8168415
Axl fusion proteins as Axl tyrosine kinase inhibitors
granted A61PA61P35/00A61P35/02
Quick answer
US patent 8168415 (Axl fusion proteins as Axl tyrosine kinase inhibitors) held by The Regents of the University of Colorado expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P7/00